TLDR
- IBM reached a key quantum computing milestone by joining and cooling two cryogenic modules to below 15 millikelvin, supporting its 2029 Quantum Starling roadmap.
- IBM unveiled a dual-architecture mainframe processor at Hot Chips, built on 2nm technology, designed to run both IBM and Arm operating systems.
- IBM stock closed at $235.68 on Aug. 21, down 21% year-to-date and 30% below its 52-week high of $332.46.
- Q2 2026 revenue rose just 1% to $17.2 billion, with IBM Z mainframe revenue plunging 42%, while IBM cut its full-year revenue growth outlook.
- IBM holds a consensus “Moderate Buy” rating with an average analyst price target of $251.87, implying 8.4% upside.
IBM stock is trading at $235.68, down over 21% year-to-date, even as the company rolls out back-to-back technical announcements that have caught the market’s attention.
International Business Machines Corporation, IBM
On Aug. 19, IBM announced it successfully joined and cooled two modular cryogenic systems into a single ultra-cold environment, hitting temperatures below 15 millikelvin. The architecture is built to eventually connect hundreds of quantum chips, which is one of the core engineering challenges in scaling quantum computing.
The milestone is tied directly to IBM’s planned Quantum Starling system, targeted for 2029. IBM has committed more than $10 billion over the next five years to advance quantum computing across research, manufacturing, and acquisitions.
Despite the news, the market reaction was muted. IBM stock rose just 1.9% on the day of the announcement, then fell around 1.5% the following session. Investors clearly want more than milestones right now.
New Dual-Architecture Chip Targets Arm Developers
Then on Aug. 24, IBM announced a second headline at the Hot Chips conference: a dual-architecture mainframe processor designed to run both IBM and Arm operating systems simultaneously.
Built on a 2 nanometer technology node, the chip contains 11 high-performance cores running at more than 5.7 GHz. It includes AI inference accelerators, an on-chip data processing unit, and advanced encryption capabilities. Each core can natively execute both Arm and IBM Z instructions at the same time.
The processor stems from IBM’s collaboration with Arm, announced in April 2026. IBM said the move brings access to a software ecosystem used by more than 22 million developers worldwide.
Q2 Results Put Pressure on Outlook
The backdrop to these announcements is a difficult financial picture. IBM’s Q2 2026 results, released July 22, showed revenue up just 1% year-over-year to $17.2 billion. Net income dipped 1% to $2.2 billion. Non-GAAP EPS came in at $2.93, up 5%.
IBM Z mainframe revenue was the big drag, falling 42% in the quarter as customers shifted spending toward AI infrastructure. Software revenue was a bright spot, rising 5% to $7.8 billion. Consulting revenue was flat at $5.3 billion.
IBM also walked back its full-year guidance. Management now expects constant-currency revenue growth of 4% to 5%, down from its prior forecast of above 5%.
The stock hit a 52-week low of $199.19 on July 23, the day after earnings. It has since recovered about 12.4% from that low.
Analysts currently price IBM at 19.13 times forward earnings, a discount to peers. The consensus sits at “Moderate Buy,” with an average price target of $251.87. CITIC Securities has a “Buy” rating and a $297 target. Susquehanna holds a “Neutral” with a $225 target.
Of 24 analysts covering IBM, 11 rate it “Strong Buy,” 10 say “Hold,” and one says “Strong Sell.”
Stop guessing and start investing with confidence. KnockoutStocks gives you the AI insights, market intelligence, and stock research you need to spot opportunities, cut through the noise, and make smarter investment decisions — all in one powerful platform.
Sign up today and get 50% OFF full access to our premium stock picks.
Simply use coupon code SPECIAL50 at checkout to claim your exclusive discount.







